Schrödinger, Inc.
SDGRHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeSchrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the. The $1.50B market capitalization puts SDGR squarely in small-cap range for its industry. The company operates in two segments, Software and Drug Discovery.
Market Cap
$1.50B
Beta
1.69
P/E (TTM)
—
P/E (Fwd)
-14.88
EPS (TTM)
$-0.71
EPS (Fwd)
$-1.35
ROE
-16.2%
ROA
-14.4%
Cash
$413.7M
Total Debt
$108.0M
Free CF
-$29.2M
52W Change
8.3%
Annual Financials
Cash vs Debt
Where SDGR stands vs its 150-day and 200-day moving averages
As of the August 26, 2026 close, SDGR finished 41.97% above its 150-day moving average ($14.08) and 33.18% above its 200-day moving average ($15.01). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SDGR overbought or oversold?
At the August 26, 2026 close, SDGR's RSI(14) was 70.5, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Schrödinger, Inc. holds $413.7M in cash against $108.0M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company is burning cash, with free cash flow at -$29.2M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -16.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $181.0M (2022) to $255.9M (2025), reflecting a 41% increase over the period.
Schrödinger, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Schrödinger, Inc. and its sector.